Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease

Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease

Background The efficacy and safety of wilate (human von Willebrand factor/coagulation factor VIII) in patients with von Willebrand disease (VWD) has been demonstrated in clinical trials. Here, we present real-world data on the use of wilate for the routine care of patients with VWD. Objec...

Full description

Bibliographic Details
Main Authors:	Michelle Sholzberg, Kate Khair, Hassan Yaish, George Rodgers, Maria Sol Cruz, Cesar Montaño Mejía, Zuzana Čermáková, Davide Matino, Jerome Teitel, Alpha Barrie, Sylvia Werner, Mario von Depka Prondzinski
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2021-07-01
Series:	TH Open
Subjects:	factor viii observational study prophylaxis von willebrand disease von willebrand factor
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1730283

Similar Items

von Willebrand Disease: The diagnosis and management of this bleeding disorder
by: Basim A. Abd, et al.
Published: (2020-01-01)

[Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease]
by: Giancarlo Castaman
Published: (2016-06-01)

Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)
by: Auerswald G, et al.
Published: (2020-06-01)

Von Willebrand Factor Multimeric Assay in Acquired von Willebrand Disease Diagnosis: A Report of Experience from North Estonia Medical Centre
by: Marika Pikta, et al.
Published: (2021-06-01)

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
by: Castaman G, et al.
Published: (2016-06-01)

Von Willebrand's disease in the German shepherd dog : clinical communication
by: R.G. Lobetti, et al.
Published: (2000-07-01)

GENÉTICA MOLECULAR DE LA HEMOFILIA A EN UNA FAMILIA COLOMBIANA CON DIAGNÓSTICO DE ENFERMEDAD DE VON WILLEBRAND Y DE HEMOFILIA A
by: Diana Carolina Polanía Villanueva, et al.
Published: (2014-12-01)

Recombinant von Willebrand Factor for Pediatric Patient with von Willebrand Disease: First Report in Korea
by: Seoin Kim, et al.
Published: (2021-04-01)

Patient with von Willebrand Disease for Gynaecologic Surgery - Perianaesthetic Concerns
by: Rakesh Garg, et al.
Published: (2008-01-01)

Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1
by: Daniel Simon, et al.
Published: (2003-12-01)

Investigating the Genetic Basis of Type 3 of Von Willebrand Disease (VWD)
by: Bowman, MACKENZIE
Published: (2013)

Perioperative management of a pediatric patient with suspected type 1 von Willebrand disease undergoing tonsillectomy: a case report
by: Hiroyuki Oshika, et al.
Published: (2019-08-01)

Human plasma-derived FVIII/VWD concentrate (Biostate): a review of experimental and clinical pharmacokinetic, efficacy and safety data
by: Paul Harper, et al.
Published: (2016-04-01)

Factors VIII and von Willebrand levels in women undergoing Assisted Reproduction: are their levels associated with clinical pregnancy outcome?
by: Monica Attanasio, et al.
Published: (2020-08-01)

Enfermedad de von Willebrand adquirida. Aspectos generales Acquired von Willebrand’s disease. General aspects
by: Alina Díaz Concepción
Published: (2004-04-01)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
by: Eric Manderstedt, et al.
Published: (2018-01-01)

Evaluation of a new semi-automated Hydragel 11 von Willebrand factor multimers assay kit for routine use
by: Pikta Marika, et al.
Published: (2021-01-01)

A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9
by: Jessica Garcia, et al.
Published: (2020-01-01)

Effect of Levothyroxine Administration on Hemostatic Analytes in Doberman Pinschers with von Willebrand's Disease
by: Heseltine-Heal, Johanna Colleen
Published: (2014)

Avaliação de alterações moleculares nos genes do FVW e da ADAMTS 13 e sua correlação com os niveis plasmaticos de FVIII e FVW em pacientes com trombose venenosa profunda
by: Bittar, Luis Fernando, 1980-
Published: (2009)

Common and Rare Variants in Genes Associated with von Willebrand Factor Level Variation: No Accumulation of Rare Variants in Swedish von Willebrand Disease Patients
by: Eric Manderstedt, et al.
Published: (2020-10-01)

Development of von Willebrand Factor Zebrafish Mutant Using CRISPR/Cas9 Mediated Genome Editing
by: Toffessi Tcheuyap, Vanina
Published: (2017)

Active von Willebrand Factor in patients with a bleeding diathesis
by: Lisa N. van der Vorm, et al.
Published: (2020-12-01)

The Osteoprotegerin - Von Willebrand Factor Complex: Protagonist Or Bystander In Atherothrombosis?
by: Nagy Elod
Published: (2016-06-01)

The Importance and Complications of Sequencing of Von Willebrand Gene in Von Willebrand Disease
by: Zolkova J, et al.
Published: (2019-04-01)

Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients <12 Years of Age with Hemophilia A (SWIFTLY-HA Study)
by: Djambas Khayat C, et al.
Published: (2021-06-01)

Influence of canine donor plasma hemostatic protein concentration on quality of cryoprecipitate
by: Macy Drinkhouse, et al.
Published: (2019-01-01)

Zebrafish Von Willebrand Factor
by: Carrillo, Maira M.
Published: (2012)

Quantitative 3D microscopy highlights altered von Willebrand factor α‐granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms
by: Maurice Swinkels, et al.
Published: (2021-08-01)

Acquired von Willebrand Syndrome in Patients With Ventricular Assist Device
by: Antoine Rauch, et al.
Published: (2019-02-01)

A preliminary analysis of platelet von willebrand factor oligosaccharides
by: Kagami, Kazuo, et al.
Published: (2000)

Perioperative management of von Willebrand patients at the time of implant placement: Case report
by: Hiroyuki Takashima, et al.
Published: (2021-09-01)

Effects of Plasmin on von Willebrand Factor and Platelets: A Narrative Review
by: Lisa N. van der Vorm, et al.
Published: (2018-04-01)

PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES
by: Stefano Lancellotti, et al.
Published: (2013-09-01)

Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia
by: Monica Sacco, et al.
Published: (2020-03-01)

Uso do DDAVP e do concentrado de CFvW/FVIII em pacientes com doença de Von Willebrand do Hemocentro de Belo Horizonte entre 2011 e 2013
by: Andréa Vilela de Oliveira Santos
Published: (2017)

Uso do DDAVP e do concentrado de CFvW/FVIII em pacientes com doença de Von Willebrand do Hemocentro de Belo Horizonte entre 2011 e 2013
by: Santos, Andréa Vilela de Oliveira
Published: (2017)

Von Willebrand Disease in the elderly: clinical perspectives
by: Chapin J
Published: (2018-08-01)

INVESTIGATION OF RISTOCETIN-INDUCED PLATELET AGGREGATION, PARAMETERS OF VON WILLEBRAND FACTOR AND THE COAGULATION FACTOR VIII AT ESSENTIAL ARTERIAL HYPERTENSION IN CHILDREN
by: M. V. Gomellya
Published: (2014-02-01)

The Influence of Sequence Variation on von Willebrand Factor Biosynthesis, Proteolytic Processing and Clearance
by: Pruss, Cynthia Marie
Published: (2010)